ARTN and breast cancer: Using nanoparticles containing bupivacaine, a non-opioid analgesic, the researchers were able to block cytokines and neurotrophic factors produced by breast cancer cells, reducing neuron cell growth and obtaining a decrease in tumour size in a mice model of breast cancer [62].